The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy

被引：0
|
作者：
M. E. Straver
E. J. Th. Rutgers
S. Rodenhuis
S. C. Linn
C. E. Loo
J. Wesseling
N. S. Russell
H. S. A. Oldenburg
N. Antonini
M. T. F. D. Vrancken Peeters
机构：
[1] Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital,Department of Surgical Oncology
[2] Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital,Department of Medical Oncology
[3] Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital,Department of Radiology
[4] Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital,Department of Pathology
[5] Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital,Department of Radiotherapy
[6] Netherlands Cancer Institute—Antoni van Leeuwenhoek Hospital,Department of Biostatistics
来源：
Annals of Surgical Oncology | 2010年 / 17卷
关键词：
Trastuzumab; Lobular Carcinoma; Invasive Lobular Carcinoma; Pathological Complete Response; Breast Cancer Subtype;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2411 / 2418
页数：7
相关论文
共 50 条
  • [21] Relationship of Neoadjuvant Chemotherapy Efficacy with Histopathologic Molecular Subtypes in Breast Cancer Patients
    Yildirim, Cigdem
    Teker, Fatih
    Okten, Ilker Nihat
    Gulturk, Ilkay
    Aytekin, Aydin
    Aytekin, Alper
    Yilmaz, Latif
    Afsar, cigdem Usul
    ISTANBUL MEDICAL JOURNAL, 2024, 25 (04): : 274 - 280
  • [22] Pathologic complete response after neoadjuvant chemotherapy in breast cancer molecular subtypes
    Sari, E.
    Aksoy, S.
    Dogan, M.
    Altinbas, M.
    Zengin, N.
    Ozisik, Y.
    Altundag, K.
    BREAST, 2015, 24 : S99 - S99
  • [23] Gene Modules and Response to Neoadjuvant Chemotherapy in Breast Cancer Subtypes: A Pooled Analysis
    Ignatiadis, Michail
    Singhal, Sandeep K.
    Desmedt, Christine
    Haibe-Kains, Benjamin
    Criscitiello, Carmen
    Andre, Fabrice
    Loi, Sherene
    Piccart, Martine
    Michiels, Stefan
    Sotiriou, Christos
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (16) : 1996 - 2004
  • [24] Identifying novel breast cancer subtypes effect on clinical response to neoadjuvant chemotherapy
    Bhatt, N.
    Fiuza-Castinieria, C.
    Murphy, S.
    O'Connor, M.
    O'Donoghue, G. T.
    BRITISH JOURNAL OF SURGERY, 2014, 101 : 22 - 22
  • [25] Relevance of Breast Cancer Subtypes in Response Monitoring with 18F-FDG PET/CT during Neoadjuvant Chemotherapy.
    Koolen, B. B.
    Pengel, K. E.
    Wesseling, J.
    Vogel, W. V.
    Vrancken, Peeters M-J T.
    Gilhuijs, K. G.
    Rutgers, E. J.
    Valdes, Olmos R. A.
    CANCER RESEARCH, 2011, 71
  • [26] Assessing the Correlation of Rate of Pathological Complete Response and Outcome in Post Neoadjuvant Chemotherapy Setting and Molecular Subtypes of Breast Cancer
    Omair, Ahmad
    Alkushi, Abdulmohsen
    Alamri, Ghaida
    Almojel, Talal
    Alsadun, Sara
    Masuadi, Emad
    Arabi, Haitham
    Mohamed, Amin E.
    Abulkhair, Omalkhair A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)
  • [27] Race, response to chemotherapy, and outcome within clinical breast cancer subtypes
    J. R. Tichy
    A. M. Deal
    C. K. Anders
    K. Reeder-Hayes
    L. A. Carey
    Breast Cancer Research and Treatment, 2015, 150 : 667 - 674
  • [28] Race, response to chemotherapy, and outcome within clinical breast cancer subtypes
    Tichy, J. R.
    Deal, A. M.
    Anders, C. K.
    Reeder-Hayes, K.
    Carey, L. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (03) : 667 - 674
  • [29] Neoadjuvant chemotherapy in breast cancer
    Charfare, H
    Limongelli, S
    Purushotham, AD
    BRITISH JOURNAL OF SURGERY, 2005, 92 (01) : 14 - 23
  • [30] Neoadjuvant chemotherapy of breast cancer
    Garces, CA
    Cance, WG
    AMERICAN SURGEON, 2004, 70 (07) : 565 - 569
12345